m-stada 60 mg retardtabletten
morphin-hcl krewel 100 mg retardtabletten
morphin-hcl krewel 60 mg retardtabletten
morphin-hcl krewel 10 mg retardtabletten
morphin-hcl krewel 200 mg retardtabletten
morphin-hcl krewel 30 mg retardtabletten
vancomycin enterocaps 250 mg hartkapsel
vancomycin enterocaps 250 mg hartkapsel
kynmobi 10 mg, 15 mg, 20 mg, 25 mg, 30 mg packung zur einleitung der behandlung
glyburide and metformin hydrochloride- glyburide and metformin hydrochloride tablet
lake erie medical dba quality care products llc - glyburide (unii: sx6k58tvwc) (glyburide - unii:sx6k58tvwc), metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - glyburide 2.5 mg - glyburide and metformin hydrochloride tablets, usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. glyburide and metformin hydrochloride tablets are contraindicated in patients with: - renal disease or renal dysfunction (eg, as suggested by serum creatinine levels ≥1.5 mg/dl [males], ≥1.4 mg/dl [females], or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see warnings and precautions ). - known hypersensitivity to metformin hydrochloride or glyburide. - acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin. - concomitant administration of bosentan. glyburide and metformin hydrochloride tablets should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, becau